Stay updated with breaking news from From Basics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid beta with high binding potency Demonstrated
Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid beta with high binding... | March 31, 2023
Prothena Corporation plc , a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced new preclinical data from its PRX012 program, a potential...
Broad participation at this year's congress highlights Prothena's leadership in advancing next generation treatments for Alzheimer's and Parkinson's disease Oral presentation on PRX012, Prothena's
Longtime Bedford resident, Judith H. Richter, known as Judy, died Nov. 30 at Greenwich Hospital. She was 83.